Imiterere yuburayi kuri 3′-Hydroxy-3-Biphenylcarboxylic Acide Citric Acide 77-92-9

Ubwiza Bwa mbere, kandi Umukiriya w'Ikirenga ni umurongo ngenderwaho wo gutanga ubufasha bwiza cyane kubaguzi bacu.Mu minsi, twagerageje uko dushoboye kugira ngo tube bamwe mu bohereza ibicuruzwa byiza mu mahanga mu murima wacu kugira ngo twuzuze abaguzi byiyongera ku buryo bw'Uburayi kuri 3′- Hydroxy-3-Biphenylcarboxylic Acide Citric Acide 77-92-9, Binyuze mumyaka irenga 8 yubucuruzi buciriritse, ubu twakusanyije uburambe bukomeye hamwe nikoranabuhanga rigezweho mugihe cyo gukora ibicuruzwa byacu.
Ubwiza Bwa mbere, kandi Umukiriya w'Ikirenga ni umurongo ngenderwaho wo kugeza ubufasha bwiza cyane kubaguzi bacu.Mu minsi, twagerageje uko dushoboye kugira ngo tube bamwe mubatumiza ibicuruzwa hanze mu murima wacu kugirango twuzuze abaguzi bakeneye.Ubushinwa 77-92-9 na CAS 77-92-9, Dushingiye kumurongo wibyakozwe byikora, umuyoboro uhoraho wo kugura ibikoresho hamwe na sisitemu yo gukorana byihuse byakozwe mugihugu cyUbushinwa kugirango byuzuze abakiriya benshi kandi basabwa mumyaka yashize.Twategerezanyije amatsiko gufatanya nabakiriya benshi kwisi yose kugirango biteze imbere kandi bigirire akamaro! Icyizere cyawe no kwemerwa nigihembo cyiza kubikorwa byacu.Gukomeza kuba inyangamugayo, guhanga udushya no gukora neza, turateganya tubikuye ku mutima ko dushobora kuba abafatanyabikorwa mu bucuruzi kugira ngo ejo hazaza heza heza!

2′-hydroxy-3′-nitro-3-biphenylcarboxylic aside ikoreshwa nkigihe cya Eltrombopag.
Eltrombopag, yakozwe na GlaxoSmithKline (GSK) mu Bwongereza nyuma iza gukorana na Novartis mu Busuwisi, ni yo ya mbere kandi yemewe ya molekile ntoya itari peptide TPO yakira agonist ku isi.Eltrombopag yemejwe na FDA yo muri Amerika muri 2008 kugirango ivure idiopathic trombocytopenic purpura (ITP), naho muri 2014 yo kuvura anemia ikabije (AA).Ninumuti wambere wemejwe na FDA yo muri Amerika kuvura AA mumyaka 30 ishize.
Ukuboza2012, FDA yo muri Amerika yemeye Eltrombopag kuvura trombocytopenia ku barwayi barwaye hepatite C idakira (CHC), ku buryo abarwayi ba hepatite C bafite uburwayi buke buterwa na platine nkeya bashobora gutangira kandi bagakomeza kuvura bisanzwe bishingiye ku ndwara z’umwijima.Ku ya 3 Gashyantare 2014, GlaxoSmithKline yatangaje ko FDA yatanze impamyabumenyi y’ubuvuzi ya Eltrombopag yo kuvura indwara ya hémopenia ku barwayi bafite imiti ikaze y’imiti idakira (SAA) ititabira byimazeyo ubudahangarwa bw'umubiri.Ku ya 24 Kanama 2015, FDA yo muri Amerika yemeje Eltrombopag kuvura trombocytopenia ku bantu bakuru ndetse n’abana bafite imyaka 1 n’imyaka irenga hamwe na immunite trombocytopenia idakira (ITP) badafite ibisubizo bidahagije kuri corticosteroide, immunoglobuline cyangwa splenectomy.Ku ya 4 Mutarama 2018, Eltrombopag yemerewe gushyirwa ku rutonde mu Bushinwa kugira ngo ivurwe mbere na mbere na trombocytopenia (ITP).

Ubwiza Bwa mbere, kandi Umukiriya w'Ikirenga ni umurongo ngenderwaho wo gutanga ubufasha bwiza cyane kubaguzi bacu.Mu minsi, twagerageje uko dushoboye kugira ngo tube bamwe mu bohereza ibicuruzwa byiza mu mahanga mu murima wacu kugira ngo twuzuze abaguzi byiyongera ku buryo bw'Uburayi kuri 3′- Hydroxy-3-Biphenylcarboxylic Acide Citric Acide 77-92-9, Binyuze mumyaka irenga 8 yubucuruzi buciriritse, ubu twakusanyije uburambe bukomeye hamwe nikoranabuhanga rigezweho mugihe cyo gukora ibicuruzwa byacu.
Imiterere yuburayi kuriUbushinwa 77-92-9 na CAS 77-92-9, Dushingiye kumurongo wibyakozwe byikora, umuyoboro uhoraho wo kugura ibikoresho hamwe na sisitemu yo gukorana byihuse byakozwe mugihugu cyUbushinwa kugirango byuzuze abakiriya benshi kandi basabwa mumyaka yashize.Twategerezanyije amatsiko gufatanya nabakiriya benshi kwisi yose kugirango biteze imbere kandi bigirire akamaro! Icyizere cyawe no kwemerwa nigihembo cyiza kubikorwa byacu.Gukomeza kuba inyangamugayo, guhanga udushya no gukora neza, turateganya tubikuye ku mutima ko dushobora kuba abafatanyabikorwa mu bucuruzi kugira ngo ejo hazaza heza heza!